Percent Free PSA

ورودی‌های بالینی بیمار

حداقل ۰.۰۱ — حداکثر ۵۰ • واحد: ng/mL

حداقل ۰.۱ — حداکثر ۱۰۰ • واحد: ng/mL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
pct free
—%
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low25.1–100
  • Intermediate10–25
  • High0–9.9
Direct Clinical Answer

The Percent Free PSA calculates evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk. Key inputs include free psa. Scores guide initiating medical expulsive or alpha-blocker therapy, ordering renal imaging, or scheduling surgical intervention. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Percent free PSA = (free PSA / total PSA) × 100. In the total PSA 4-10 ng/mL range: >25% low, 10-25% intermediate, <10% high probability of prostate cancer on biopsy.

Clinical Indication

The Percent Free PSA is indicated for bedside clinical practice to support Percent free PSA = (free PSA / total PSA) × 100. In the total PSA 4-10 ng/mL range: >25% low, 10-25% intermediate, <10% high probability of prostate cancer on biopsy.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.

Limitations & Contraindications

Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.

Clinical Pearls & Action Plan

Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression.

Formula & Variables:

%fPSA = (free / total) × 100.

Input Parameters

NameTypeRequiredDescription
free_psafloatYesFree PSA(ng/mL)
total_psafloatYesTotal PSA(ng/mL)

Score Interpretation & Guidance

RangeStageDescription
25.1–100LowLow probability
10–25IntermediateIntermediate probability
0–9.9HighHigh probability

Evidence-Based References (EBM)

  • Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. JAMA. 1998;279(19):1542-1547.

Related calculators